Cat1 forms filament networks to degrade NAD(+) during the type III CRISPR-Cas antiviral response Journal Article


Authors: Baca, C. F.; Majumder, P.; Hickling, J. H.; Patel, D. J.; Marraffini, L. A.
Article Title: Cat1 forms filament networks to degrade NAD(+) during the type III CRISPR-Cas antiviral response
Abstract: Type III CRISPR-Cas systems defend against viral infection in prokaryotes by using an RNA-guided complex that recognizes foreign transcripts and synthesizes cyclic oligoadenylate (cOA) messengers to activate CRISPR-associated Rossmann-fold (CARF) immune effectors. In this study, we investigated a protein containing a CARF domain-fused Toll/interleukin-1 receptor (TIR) domain, Cat1. We found that Cat1 provides immunity by cleaving and depleting oxidized nicotinamide adenine dinucleotide (NAD+) molecules from the infected host, inducing a growth arrest that prevents viral propagation. Cat1 forms dimers that stack upon each other to generate long filaments that are maintained by bound cOA ligands, with stacked TIR domains forming the NAD+ cleavage catalytic sites. Furthermore, Cat1 filaments assemble into distinct trigonal and pentagonal networks that enhance NAD+ degradation. Cat1 presents an unprecedented chemistry and higher-order protein assembly for the CRISPR-Cas response.
Keywords: genetics; protein domain; metabolism; chemistry; protein multimerization; catalytic domain; nad; nicotinamide adenine dinucleotide; enzyme active site; protein domains; crispr-associated proteins; adenine nucleotides; adenine nucleotide; crispr associated protein; crispr cas system; crispr-cas systems
Journal Title: Science
Volume: 388
Issue: 6752
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 2025-06-12
Start Page: eadv9045
Language: English
DOI: 10.1126/science.adv9045
PUBMED: 40208959
PROVIDER: scopus
PMCID: PMC12162218
DOI/URL:
Notes: Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding authors are Puja Majumder and Dinshaw Patel -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dinshaw J Patel
    478 Patel